Covella Pharmaceuticals
2007
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Provider of bio-technical services. The company engages in providing VLA-1 neutralizing antibodies for the multiple inflammatory and autoimmune diseases.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- DE
- United States
Covella Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Covella Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookCovella Pharmaceuticals Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Mark Totoritis MD | Co-Founder | ||
| Matthew Strobeck Ph.D | Co-Founder |
1 Former Executive
You’re viewing 2 of 3 executives. Get the full list »